Concepedia

Anne-Marie Martin

AM

Statistics

Publications

7

Citations

7.3K

H-Index

7

Active since

2003

Affiliations

GlaxoSmithKline (United States)(Current)

University of Lübeck

University Hospital Schleswig-Holstein

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

Anne-Marie Martin is an author at GlaxoSmithKline (United States) specializing in oncology, radiation oncology, and medicine.

Top concepts

Publications per year

2003–2014

7

Publications

7

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Axel Hauschild, Jean‐Jacques Grob, Lev Demidov et al. · The Lancet · 2012 · 2.9K citations

, , +6

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

Caroline Robert, Bogusława Karaszewska, Jacob Schachter et al. · New England Journal of Medicine · 2014 · 2.6K citations · Full text

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

Georgina V. Long, Uwe Trefzer, Michael A. Davies et al. · The Lancet Oncology · 2012 · 901 citations

, , +6

Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma

Paolo A. Ascierto, David R. Minor, Antoni Ribas et al. · Journal of Clinical Oncology · 2013 · 422 citations

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

Hai T. Tran, Yuan Liu, Amado J. Zurita et al. · The Lancet Oncology · 2012 · 260 citations

, , +8

1–5 of 7